Evidence map›Paper›PMID 20012133›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2010

Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer.

J-Matthias von der Schulenburg, Anne Prenzler, Willemien Schurer

Abstract read
PubMed Publisher
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The dynamics of colorectal cancer management in 17 countries.The European journal of health economics : HEPAC : health economics in prevention and care · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

J-Matthias von der SchulenburgLeibniz University Hannover, Hannover, Germany. jms@ivbl.uni-hannover.de
Anne Prenzler
Willemien Schurer
Leibniz University Hannover · DELondon School of Economics and Political Science · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

Indexed as

Reimbursement MechanismsAdultAgedColorectal NeoplasmsDiagnosis-Related GroupsFemaleGermanyHealth PolicyHumansInsurance, HealthInterviews as TopicMaleMass ScreeningMiddle AgedRegistriesReview Literature as Topic

Identifiers

PMID20012133
OpenAlexW2054109482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.